Revolutionizing Therapeutics
Karivax leverages technology to improve healthcare for everyone
SAPN Applications
Precision nanoparticles for immune response modulation and cancer treatment
SAPN is stable and easier to manufacture, enabling rapid vaccine development.
provide versatile covering to ensure proper drug delivery while preventing degradation.
About Us
Karivax is an emerging Biotech startup dedicated to the research, development, and commercialization of a diverse platform of nanoparticles that focus on immune response precision, targeted cancer therapies, and improved delivery mechanisms in the prevention, treatment, and management of emerging infectious diseases and cancer immunotherapy.
